Development of a meningioma in a patient with acromegaly during octreotide treatment: Are there any causal relationships?
- 32 Downloads
Somatostatin receptors are highly expressed in almost all meningiomas but in this setting their functional role is not clear. A 59-yrold woman had been treated with octreotide after an unsuccessful operation for a GH-secreting pituitary adenoma. After 8 yr of treatment, a nuclear magnetic resonance (NMR) scan disclosed a 3 cm meningioma of the tentorium. Mean GH was 2.2 ng/ml and IGF-I 325 ng/ml. Meningioma was resected and tissue was digested to obtain tumor cell suspension. Aim of the study was to measure epidermal growth factor (EGF)-induced proliferation of cultured meningioma cells in the presence of either somatostatin or octreotide. Cells were grown to semiconfluency in Dolbecco’s modified eagle medium (D-MEM) supplemented with 10% fetal calf serum (FCS). After 48 h in D-MEM without serum, the medium was replaced by fresh medium plus recombinant EGF (10 ng/ml) and somatostatin or octreotide were added in the final concentrations of 1,10 and 100 nM. 20 h later 1 μcgCi of 3H-thymidine was added to each well. After 4 h, incorporated radioactivity was measured. While octreotide did not influence significantly cell growth at the three dose tested, somatostatin increased thymidine incorporation dose-dependently (peak 100nM: 150%±27% vs medium plus EGF, p<0.05). Octreotide effectively suppressed GH secretion in our acromegalic patient but is unlikely that its long-term use could have stimulated the growth of meningioma since it did not significantly influence the in vitro proliferation of the meningioma cells. These results suggest that somatostatin-mediated proliferative effect on meningioma cells is not mediated by the subtype 2 of the somatostatin receptor.
Key-wordsacromegaly meningioma somatostatin octreotide somatostatin receptors
Unable to display preview. Download preview PDF.
- 8.Schultz S., Pauli S.U., Schulz S., et al. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype SSTR2A. Clin. Cancer Res. 2000, 6: 1865–1874.Google Scholar
- 13.Weckebecker G., Tolcsvai L., Stolz B., Pollack M., Bruns C. Somatostatin analogue octreotide enhances the antineo-plastic effect of tamoxifen and ovariectomy on 7, 12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res. 1994, 54: 6334–6337.Google Scholar
- 15.Garcia-Luna P.P., Relimpio F., Pumar A., et al. Clinical use of octreotide in unresectable meningiomas. A report of three cases. J. Neuro. Sci. 1993, 37: 237–241.Google Scholar
- 23.Antoniades H.N., Galanopoulos T., Neville-Golden J., Maxwell M. Expression of insulin-like growth factors-I and II and their receptors mRNAs in primary human astrocy-tomas and meningiomas: in vitro studies using in vitro hybridization and immunocytochemistry. Int. J. Cancer 1992, 50: 215–222.PubMedCrossRefGoogle Scholar